Search Results for “ diabetes” – Page 45 – media

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Advanced Cervical Cancer

First Filing Acceptance for an Anti-PD-1 Therapy in Cervical Cancer
- Source: investors.merck
- 633
- May 2, 2018
cervical cancer FDA keytruda Merck
FDA to expedite review of IDx-DR, a breakthrough AI diagnostic system

IDx, a privately held AI diagnostics company, announced today that it has filed its De Novo submission to the FDA for IDx-DR, an AI-based system for the autonomous detection of diabetic retinopathy — a leading cause of blindness. The FDA has granted IDx-DR with a “Breakthrough Device” designation, which means the submission will receive expedited review.
- Source: prweb
- 666
- April 26, 2018
blindness diabetic retinopathy FDA IDx-DR New Approvals
UCSD launching pilot trial of glucose-sensing ‘tattoo’

Researchers from the University of California San Diego have developed a low-cost, single-use tattoo-like wearable that measures the user’s glucose levels. According to a release from the institution, this noninvasive technology will be at the center of a newly announced pilot clinical trial designed to test the accuracy and acceptability of the tattoos.
- Source: MobiHealthNews
- 603
- April 25, 2018
blood glucose Researches
How health apps factor into a $950B ecosystem

Highlighting the ubiquity and importance of smartphones across multiple industries, a new report by ACT | The App Association indicated that two out of three businesses utilize enterprise apps. And many of those opportunities are rising up throughout the healthcare industry.
- Source: Fierce Healthcare
- 636
- April 24, 2018
healthcare Market Views mHealth
mHealth App Aims to Help Caregivers Identify Perinatal Depression

The mHealth app, designed by researchers at the Worcester Polytechnic Institute, helps obstetric care providers identify perinatal depression in soon-to-be and new mothers and gives them care management tips.
- Source: mHealth Intelligence
- 648
- April 24, 2018
mHealth New Approvals pregnancy
Amid tough respiratory competition, AstraZeneca inks Symbicort outcomes-based deals

It's no secret that respiratory drugs make up a crowded field, and forthcoming generics will make the competition tougher still. AstraZeneca's Symbicort is no stranger to the fallout, either, what with payers pressing prices and new rivals grabbing share.
- Source: fiercepharma
- 635
- April 20, 2018
AstraZeneca Company Insights Symbicor
Common Sensing Secures $6.6M Series A Investment Round to Support Injectable Medicines

Common Sensing , an evidence-based, data-driven injectable-medicine healthcare company, announced the close of a $6.6 million USD Series A financing. The round was led by Waterline Ventures. New World Health, Royal Philips (NYSE: PHG; AEX: PHIA), and Haselmeier joined the round as well. The funds will be used to accelerate Common Sensing's manufacturing and commercial operations for Gocap™, an IP-protected dose monitoring solution enabling patients and providers to better utilize injectable medicine, including insulin, fertility medications, growth hormones, and others.
- Source: 4-traders.
- 607
- April 18, 2018
Gocap™ injectable medicine Market Views Series
New blood pressure guidelines could put lives at risk, say experts

A new report in JAMA Internal Medicine by University of Sydney and Bond University scholars weighs the risks and benefits of a recent change to blood pressure guidelines in the US.
- Source: MedicalXpress
- 561
- April 17, 2018
blood pressure Policies
A healthcare startup to improve dose management for injectable drugs raises $6.6M

The FDA confirmed in a March 16, 2012 communication released to Bloomberg News that the vaginally placed pelvic mesh product known as the Prolift, sold by Johnson & Johnson subsidiary Ethicon, Inc. since March, 2005, was initially marketed without any clearance or approval from the FDA.
- Source: Med City News
- 515
- April 16, 2018
Company Insights digital health
FDA approves first AI-powered device to detect diabetic retinopathy

The FDA today approved the first medical device to harness artificial intelligence for the detection of diabetic retinopathy in adults who have diabetes.
- Source: Drug Delivery Business News
- 675
- April 13, 2018
AI FDA New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.